{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:24:02Z","timestamp":1789503842741,"version":"build-2803163510"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.phrs.2018.01.009","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T14:41:47Z","timestamp":1517409707000},"page":"277-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"special_numbering":"C","title":["Metabolic syndrome, autoimmunity and rheumatic diseases"],"prefix":"10.1016","volume":"133","author":[{"given":"Gabriela","family":"Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vera-Lastra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Lilia","family":"Peralta-Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Pilar","family":"Jim\u00e9nez-Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Pilar","family":"Cruz-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.","family":"Jara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.phrs.2018.01.009_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006103","article-title":"The metabolic syndrome and risk of sudden cardiac death: the atherosclerosis risk in communities study","volume":"63","author":"Hess","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.phrs.2018.01.009_bib0010","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cmet.2017.02.006","article-title":"The role of the immune system in metabolic health and disease","volume":"25","author":"Zmora","year":"2017","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0015","first-page":"1101","article-title":"Adipokines in connective tissue diseases","volume":"34","author":"Sawicka","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0020","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.semarthrit.2014.12.002","article-title":"Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: baseline data of the CARMA Project","volume":"44","author":"Casta\u00f1eda","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.phrs.2018.01.009_bib0025","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2018.01.009_bib0030","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1590\/S0036-36342010000700004","article-title":"Metabolic syndrome in Mexican adults. Results from the national health and nutrition survey 2006","volume":"52","author":"Rojas","year":"2010","journal-title":"Salud Publica Mex."},{"key":"10.1016\/j.phrs.2018.01.009_bib0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ecl.2008.06.001","article-title":"An integrated view of insulin resistance and endothelial dysfunction","volume":"37","author":"Muniyappa","year":"2008","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.phrs.2018.01.009_bib0040","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2018.01.009_bib0045","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2008-0425","article-title":"Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance","volume":"93","author":"Hivert","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.diabet.2007.09.004","article-title":"Adipokines: the missing link between insulin resistance and obesity","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"Diabetes Metab."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0055","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1038\/s41598-017-09723-y","article-title":"Body fat distribution and the risk of incident metabolic syndrome: a longitudinal cohort study","volume":"7","author":"Kwon","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0060","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/j.2040-4603.2017.tb00780.x","article-title":"Adaptive immunity and metabolic health harmony becomes dissonant in obesity and aging","volume":"7","author":"Bharath","year":"2017","journal-title":"Compr. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0065","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: a link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J. Cardiol."},{"issue":"November","key":"10.1016\/j.phrs.2018.01.009_bib0070","first-page":"30351","article-title":"IL-1 family cytokines in cardiovascular disease","volume":"17","author":"Pfeiler","year":"2017","journal-title":"Cytokine"},{"issue":"October","key":"10.1016\/j.phrs.2018.01.009_bib0075","first-page":"30315","article-title":"The IL-12 cytokine family in cardiovascular diseases","volume":"17","author":"van der Heijden","year":"2017","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.phrs.2018.01.009_bib0080","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.imbio.2012.03.002","article-title":"Increased activity of interleukin-23\/interleukin-17 cytokine axis in primary antiphospholipid syndrome","volume":"218","author":"Popovic-Kuzmanovic","year":"2013","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0085","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41598-017-06997-0","article-title":"Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome","volume":"7","author":"Fr\u00fchbeck","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2018.01.009_bib0090","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phrs.2018.01.009_bib0095","first-page":"169","article-title":"Metabolic syndrome in inflammatory rheumatic diseases","volume":"58","author":"Malesci","year":"2006","journal-title":"Reumatismo"},{"issue":"5","key":"10.1016\/j.phrs.2018.01.009_bib0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.autrev.2009.01.001","article-title":"Metabolic syndrome in rheumatological diseases","volume":"8","author":"Pereira","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0105","first-page":"337","article-title":"Gut microbiota, obesity and metabolic disorders","volume":"63","author":"Federico","year":"2017","journal-title":"Minerva Gastroenterol. Dietol."},{"issue":"September","key":"10.1016\/j.phrs.2018.01.009_bib0110","article-title":"The role of gut microbiota in the pathogenesis of rheumatic diseases","author":"Zhong","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00296-016-3464-9","article-title":"The metabolic profile in early rheumatoid arthritis: a high prevalence of metabolic obesity","volume":"37","author":"M\u00fcller","year":"2017","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.009_bib0120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3899\/jrheum.150757","article-title":"Higher prevalence of metabolic syndrome in patients with psoriatic arthritis: a comparison with a control group of noninflammatory rheumatologic conditions","volume":"43","author":"Haroon","year":"2016","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.phrs.2018.01.009_bib0125","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1136\/annrheumdis-2013-203933","article-title":"Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort","volume":"74","author":"Parker","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0130","first-page":"476","article-title":"Prevalence of metabolic syndrome and insulin resistance in systemic sclerosis: prevalence of metabolic syndrome and insulin resistance in system sclerosis","volume":"53","author":"Peralta-Amaro","year":"2015","journal-title":"Rev. Med. Inst. Mex. Seguro Soc."},{"key":"10.1016\/j.phrs.2018.01.009_bib0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/acr.21879","article-title":"Analysis of metabolic syndrome in adult dermatomyositis with a focus on cardiovascular disease","volume":"65","author":"de Moraes","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.phrs.2018.01.009_bib0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/rheumatology\/kes345","article-title":"Metabolic syndrome in ANCA-associated vasculitis","volume":"52","author":"Petermann Smits","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.autrev.2010.10.004","article-title":"Prevalence of metabolic syndrome in primary antiphospholipid syndrome patients","volume":"10","author":"Medina","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.phrs.2018.01.009_bib0150","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.amjmed.2016.06.040","article-title":"Update on importance of diet in gout","volume":"129","author":"Beyl","year":"2016","journal-title":"Am. J. Med."},{"issue":"12","key":"10.1016\/j.phrs.2018.01.009_bib0155","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/15257770.2011.596499","article-title":"Comorbidities in patients with gout","volume":"30","author":"Ichikawa","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0160","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13075-017-1416-8","article-title":"Gout and comorbidity: a nominal group study of people with gout","volume":"19","author":"Singh","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"4-6","key":"10.1016\/j.phrs.2018.01.009_bib0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/15257770.2013.853785","article-title":"Metabolic syndrome in primary gout","volume":"33","author":"Gonz\u00e1lez-Senac","year":"2014","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"7","key":"10.1016\/j.phrs.2018.01.009_bib0170","first-page":"1350","article-title":"Gout, diet, and the insulin resistance syndrome","volume":"29","author":"Fam","year":"2002","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.009_bib0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/BOR.0b013e32835d951e","article-title":"Metabolic syndrome, diabetes, and hyperuricemia","volume":"25","author":"Li","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"issue":"17","key":"10.1016\/j.phrs.2018.01.009_bib0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13075-015-0593-6","article-title":"Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study","volume":"24","author":"Lee","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.009_bib0185","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.rdc.2014.01.001","article-title":"Epidemiology of gout","volume":"40","author":"Roddy","year":"2014","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0190","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/1756-185X.12007","article-title":"Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions","volume":"15","author":"Gheita","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/acr.21824","article-title":"Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: a prospective study","volume":"65","author":"Chen","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3892\/br.2017.966","article-title":"The role of hyperuricemia on vascular endothelium dysfunction","volume":"7","author":"Zhen","year":"2017","journal-title":"Biomed. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0205","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0028-1102947","article-title":"Effects of benzbromarone and allopurinol on adiponectin in vivo and in vitro","volume":"41","author":"Inokuchi","year":"2009","journal-title":"Horm. Metab. Res."},{"issue":"26","key":"10.1016\/j.phrs.2018.01.009_bib0210","doi-asserted-by":"crossref","first-page":"e935","DOI":"10.1097\/MD.0000000000000935","article-title":"A prospective follow-up of adipocytokines in cohort patients with gout: association with metabolic syndrome but not with clinical inflammatory findings: strobe-compliant article","volume":"94","author":"Garc\u00eda-M\u00e9ndez","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0215","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.39107","article-title":"A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout","volume":"67","author":"Vieira","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.009_bib0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/BOR.0000000000000366","article-title":"Factors modulating the inflammatory response in acute gouty arthritis","volume":"29","author":"Cleophas","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0225","doi-asserted-by":"crossref","first-page":"20602","DOI":"10.1038\/srep20602","article-title":"Intestinal microbiota distinguish gout patients from healthy humans","volume":"8","author":"Guo","year":"2016","journal-title":"Guo Z Sci. Rep."},{"key":"10.1016\/j.phrs.2018.01.009_bib0230","doi-asserted-by":"crossref","first-page":"e0170108","DOI":"10.1371\/journal.pone.0170108","article-title":"Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1year prospective single centre study","volume":"12","author":"Ruscitti","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.01.009_bib0235","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.atherosclerosis.2007.01.004","article-title":"Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis","volume":"196","author":"Chung","year":"2008","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.phrs.2018.01.009_bib0240","doi-asserted-by":"crossref","first-page":"e78151","DOI":"10.1371\/journal.pone.0078151","article-title":"The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.01.009_bib0245","doi-asserted-by":"crossref","first-page":"e0170361","DOI":"10.1371\/journal.pone.0170361","article-title":"Metabolic syndrome and its components among rheumatoid arthritis patients: a comprehensive updated systematic review and meta-analysis","volume":"12","author":"Hallajzadeh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.01.009_bib0250","doi-asserted-by":"crossref","first-page":"e7862","DOI":"10.1097\/MD.0000000000007862","article-title":"Disease duration of rheumatoid arthritis is a predictor of vascular stiffness: a cross-sectional study in patients without known cardiovascular comorbidities: a STROBE-compliant article","volume":"96","author":"V\u00e1zquez-Del Mercado","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.phrs.2018.01.009_bib0255","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13075-015-0549-x","volume":"17","author":"Parra-Salcedo","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2018.01.009_bib0260","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrrheum.2014.121","article-title":"Rheumatoid arthritis and metabolic syndrome","volume":"10","author":"Kerekes","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0265","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jcsm.12189","article-title":"Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis","volume":"8","author":"Tournadre","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.phrs.2018.01.009_bib0270","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jbspin.2016.09.001","article-title":"Rheumatoid arthritis, insulin resistance, and diabetes","volume":"84","author":"Nicolau","year":"2017","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.phrs.2018.01.009_bib0275","doi-asserted-by":"crossref","first-page":"9670434","DOI":"10.1155\/2017\/9670434","article-title":"Abnormal glucose metabolism in rheumatoid arthritis","volume":"2017","author":"Pi","year":"2017","journal-title":"BioMed. Res. Int."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0280","doi-asserted-by":"crossref","first-page":"e0128889","DOI":"10.1371\/journal.pone.0128889","article-title":"Effects of tumour necrosis factor antagonists on insulin sensitivity\/resistance in rheumatoid arthritis: a systematic review and meta-analysis","volume":"10","author":"Burska","year":"2015","journal-title":"PLoS One"},{"issue":"August","key":"10.1016\/j.phrs.2018.01.009_bib0285","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.biopha.2017.05.055","article-title":"Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy","volume":"92","author":"Alam","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2018.01.009_bib0290","doi-asserted-by":"crossref","first-page":"343746","DOI":"10.1155\/2014\/343746","article-title":"Adipokines, metabolic syndrome and rheumatic diseases","volume":"2014","author":"Abella","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2018.01.009_bib0295","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrrheum.2016.209","article-title":"Leptin in the interplay of inflammation,metabolism and immune system disorders","volume":"13","author":"Abella","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2018.01.009_bib0300","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/08916934.2016.1230847","article-title":"Baseline adiponectin and leptin levels in predicting an increased risk of disease activity in rheumatoid arthritis: a meta-analysis and systematic review","volume":"49","author":"Cao","year":"2016","journal-title":"Autoimmunity"},{"key":"10.1016\/j.phrs.2018.01.009_bib0305","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13075-015-0850-8","article-title":"Serum leptin and serum leptin\/serum leptin receptor ratio imbalance in obese rheumatoid arthritis patients positive for anti-cyclic citrullinated peptide antibodies","volume":"17","author":"G\u00f3mez-Ba\u00f1uelos","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"July","key":"10.1016\/j.phrs.2018.01.009_bib0310","article-title":"Association between serum\/plasma adiponectin levels and immune-mediated diseases: a meta-analysis","author":"Zhang","year":"2017","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.phrs.2018.01.009_bib0315","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s10067-015-2955-5","article-title":"Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis","volume":"34","author":"Huang","year":"2015","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0320","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.reuma.2015.11.011","article-title":"Peripheral blood leptin and resistin levels as clinical activity biomarkers in Mexican rheumatoid arthritis patients","volume":"12","author":"Bustos Rivera-Bahena","year":"2016","journal-title":"Reumatol. Clin."},{"key":"10.1016\/j.phrs.2018.01.009_bib0325","first-page":"6","article-title":"Circulating adiponectin and visfatin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis","volume":"1","author":"Lee","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.phrs.2018.01.009_bib0330","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s40618-016-0457-1","article-title":"The relationship between visfatin and serum concentrations of C-reactive protein, interleukin 6 in patients with metabolic syndrome","volume":"39","author":"Hosseinzadeh-Attar","year":"2016","journal-title":"J. Endocrinol. Invest."},{"issue":"10","key":"10.1016\/j.phrs.2018.01.009_bib0335","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.amjmed.2012.01.025","article-title":"Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis","volume":"125","author":"Baker","year":"2012","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0340","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10238-014-0323-4","article-title":"Metabolic syndrome and chronic arthritis: effects of anti-TNF-\u03b1 therapy","volume":"15","author":"Maruotti","year":"2015","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0345","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13073-016-0299-7","article-title":"An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis","volume":"8","author":"Chen","year":"2016","journal-title":"Genome Med."},{"issue":"10","key":"10.1016\/j.phrs.2018.01.009_bib0350","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.phrs.2018.01.009_bib0355","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1002\/art.11296","article-title":"Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study","volume":"48","author":"Bruce","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.phrs.2018.01.009_bib0360","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0961203313502570","article-title":"SLE and metabolic syndrome","volume":"22","author":"Parker","year":"2013","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.phrs.2018.01.009_bib0365","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/1756-185X.13153","article-title":"Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: a meta-analysis","volume":"20","author":"Sun","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2018.01.009_bib0370","doi-asserted-by":"crossref","first-page":"i55","DOI":"10.1093\/rheumatology\/kew427","article-title":"Pathways leading to an immunological disease: systemic lupus erythematosus","volume":"56","author":"Zharkova","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.phrs.2018.01.009_bib0375","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/icb.2017.53","article-title":"Cytokines in systemic lupus erythematosus: far beyond Th1\/Th2 dualism lupus: cytokine profiles","volume":"95","author":"Guimar\u00e3es","year":"2017","journal-title":"Immunol. Cell Biol."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.009_bib0380","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0961203315603138","article-title":"Metabolic syndrome is associated with decreased circulating endothelial progenitor cells and increased arterial stiffness in systemic lupus erythematosus","volume":"25","author":"Castejon","year":"2016","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0385","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12026-016-8808-8","article-title":"Emerging role of adipokines in systemic lupus erythematosus","volume":"64","author":"Li","year":"2016","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0390","first-page":"636","article-title":"Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results","volume":"20","author":"Margiotta","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"August","key":"10.1016\/j.phrs.2018.01.009_bib0395","article-title":"Effects of risk factors for and components of metabolic syndrome on the quality of life of patients with systemic lupus erythematosus: a structural equation modeling approach","volume":"22","author":"Lee","year":"2017","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.phrs.2018.01.009_bib0400","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/ken121","article-title":"Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences","volume":"47","author":"Ruiz-Irastorza","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0405","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/0961203316668040","article-title":"25-Hydroxyvitamin D is associated with metabolic syndrome among premenopausal women with systemic lupus erythematosus in China","volume":"26","author":"Wang","year":"2017","journal-title":"Lupus"},{"issue":"July","key":"10.1016\/j.phrs.2018.01.009_bib0410","first-page":"30106","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"16","author":"Chaturvedi","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.phrs.2018.01.009_bib0415","doi-asserted-by":"crossref","first-page":"621270","DOI":"10.1155\/2014\/621270","article-title":"Cardiovascular risk factors in the antiphospholipid syndrome","volume":"2014","author":"da Silva","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"10","key":"10.1016\/j.phrs.2018.01.009_bib0420","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/acr.21701","article-title":"Association of arterial events with the coexistence of metabolic syndrome and primary antiphospholipid syndrome","volume":"64","author":"Rodrigues","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0425","first-page":"871","article-title":"Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome","volume":"30","author":"Rodrigues","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0430","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11926-014-0472-1","article-title":"The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome","volume":"17","author":"Ruff","year":"2015","journal-title":"Rheumatol. Rep."},{"issue":"11","key":"10.1016\/j.phrs.2018.01.009_bib0435","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0440","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jbspin.2010.05.001","article-title":"Spondyloarthropathies: an independent cardiovascular risk factor?","volume":"77","author":"Mathieu","year":"2010","journal-title":"Jt. Bone Spine"},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0445","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/acr.20364","article-title":"Cardiovascular profile in ankylosing spondylitis: a systematic review and metaanalysis","volume":"63","author":"Mathieu","year":"2011","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.phrs.2018.01.009_bib0450","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1749-6632.2010.05875.x","article-title":"Adipokines as novel biomarkers and regulators of the metabolic syndrome","volume":"1212","author":"Deng","year":"2010","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2018.01.009_bib0455","doi-asserted-by":"crossref","first-page":"860651","DOI":"10.1155\/2014\/860651","article-title":"Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis","volume":"2014","author":"Genre","year":"2014","journal-title":"Biomed. Res Int."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2018.22.1.1","article-title":"Role of inflammasomes in inflammatory autoimmune rheumatic diseases","volume":"22","author":"Yi","year":"2018","journal-title":"Korean J. Physiol. Pharmacol."},{"issue":"April","key":"10.1016\/j.phrs.2018.01.009_bib0465","article-title":"Metabolic syndrome in patients with ankylosing spondylitis receiving anti-TNF\u03b1 therapy: association with predictors of cardiovascular risk","author":"Maia","year":"2017","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0470","first-page":"850","article-title":"TNF-\u03b1 antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients","volume":"30","author":"Miranda-Filloy","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.phrs.2018.01.009_bib0475","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/kei145","article-title":"Impaired endothelial function in patients with ankylosing spondylitis","volume":"45","author":"Sari","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.phrs.2018.01.009_bib0480","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-0032-1306433","article-title":"Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis","volume":"38","author":"Di Minno","year":"2012","journal-title":"Semin. Thromb. Hemost."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.009_bib0485","first-page":"292","article-title":"High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity","volume":"27","author":"Papadakis","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.phrs.2018.01.009_bib0490","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/annrheumdis-2013-203854","article-title":"Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort","volume":"73","author":"Van Praet","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"123","key":"10.1016\/j.phrs.2018.01.009_bib0495","first-page":"361","article-title":"Role of gut microbiome in ankylosing spondylitis: an analysis of studies in literature","volume":"22","author":"Xu","year":"2016","journal-title":"Discov. Med."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0500","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2005.03.046","article-title":"Epidemiology of psoriatic arthritis in the population of the United States","volume":"53","author":"Gelfand","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0505","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5152\/eurjrheum.2017.16052","article-title":"Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis","volume":"4","author":"\u00d6zkan","year":"2017","journal-title":"Eur. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.phrs.2018.01.009_bib0510","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11154-016-9381-0","article-title":"Adipokines in psoriasis: an important link between skin inflammation and metabolic alterations","volume":"17","author":"Wolk","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"5","key":"10.1016\/j.phrs.2018.01.009_bib0515","doi-asserted-by":"crossref","first-page":"102","DOI":"10.17116\/terarkh2016885102-106","article-title":"Cardiovascular risk in patients with psoriatic arthritis","volume":"88","author":"Korotaeva","year":"2016","journal-title":"Ter. Arkh."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0520","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.38892","article-title":"Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease","volume":"67","author":"Scher","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.phrs.2018.01.009_bib0525","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11926-013-0407-2","article-title":"The microbiome and psoriatic arthritis","volume":"16","author":"Eppinga","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2018.01.009_bib0530","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","article-title":"The pathogenesis of systemic sclerosis","volume":"41","author":"Stern","year":"2015","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"7","key":"10.1016\/j.phrs.2018.01.009_bib0535","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00296-017-3753-y","article-title":"Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study","volume":"37","author":"Cruz-Dom\u00ednguez","year":"2017","journal-title":"Rheumatol. Int."},{"issue":"9","key":"10.1016\/j.phrs.2018.01.009_bib0540","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00296-013-2701-8","article-title":"Oxidative stress in Mexicans with diffuse cutaneous systemic sclerosis","volume":"33","author":"Cruz-Dom\u00ednguez","year":"2013","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.009_bib0545","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/14397595.2016.1193106","article-title":"Serum adipokines levels in patients with systemic sclerosis: a meta-analysis","volume":"27","author":"Zhao","year":"2017","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0550","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1756-185X.2012.01755.x","article-title":"Serum leptin, resistin and TNF-\u03b1 levels in patients with systemic sclerosis: the role of adipokines in scleroderma","volume":"15","author":"Pehlivan","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.009_bib0555","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0560","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-016-1182-z","article-title":"Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease","volume":"18","author":"Andr\u00e9asson","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"14","key":"10.1016\/j.phrs.2018.01.009_bib0565","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93340","article-title":"Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial","volume":"2","author":"Consolim-Colombo","year":"2017","journal-title":"JCI Insight"},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2018.01.009_bib0570","first-page":"56","article-title":"Antioxidant treatment with N-acetylcysteine in severe diffuse systemic sclerosis: a prospective study of 18 patients","volume":"7","author":"Cruz-Dominguez","year":"2011","journal-title":"Reumatol. Clin."},{"key":"10.1016\/j.phrs.2018.01.009_bib0575","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaut.2014.02.006","article-title":"Sj\u00f6gren's syndrome: where do we stand, and where shall we go?","volume":"51","author":"Cornec","year":"2014","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.phrs.2018.01.009_bib0580","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-015-3072-1","article-title":"Metabolic syndrome in Sj\u00f6gren's syndrome patients: a relevant concern for clinical monitoring","volume":"35","author":"Augusto","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0585","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3109\/14397595.2013.851639","article-title":"Subclinical reduced G6PD activity in rheumatoid arthritis and Sj\u00f6gren's Syndrome patients: relation to clinical characteristics, disease activity and metabolic syndrome","volume":"24","author":"Gheita","year":"2014","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0590","first-page":"754","article-title":"High prevalence of serum metabolic alterations in primary Sj\u00f6gren's syndrome: influence on clinical and immunological expression","volume":"34","author":"Ramos-Casals","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.phrs.2018.01.009_bib0595","doi-asserted-by":"crossref","first-page":"493593","DOI":"10.1155\/2014\/493593","article-title":"Anti-TNF-alpha therapy and systemic vasculitis","volume":"2014","author":"Jarrot","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0600","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.berh.2012.12.004","article-title":"Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides","volume":"27","author":"Cohen Tervaert","year":"2013","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"September","key":"10.1016\/j.phrs.2018.01.009_bib0605","article-title":"Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited","author":"Keser","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.phrs.2018.01.009_bib0610","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3899\/jrheum.130162","article-title":"High prevalence of metabolic syndrome in Takayasu arteritis: increased cardiovascular risk and lower adiponectin serum levels","volume":"40","author":"Da Silva","year":"2013","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0615","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/rheumatology\/kes345","article-title":"Metabolic syndrome in ANCA-associated vasculitis","volume":"52","author":"Petermann Smits","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.phrs.2018.01.009_bib0620","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2249.2011.04543.x","article-title":"Excessive CD4+ T cells coexpressing interleukin-17 and interferon-\u03b3 in patients with Beh\u00e7et\u2019s disease","volume":"168","author":"Shimizu","year":"2012","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2018.01.009_bib0625","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40257-013-0034-8","article-title":"Prevalence of metabolic syndrome in Beh\u00e7et disease: a case-control study in Turkey","volume":"14","author":"Yal\u00e7\u0131n","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"issue":"2","key":"10.1016\/j.phrs.2018.01.009_bib0630","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2133.2002.04703.x","article-title":"Serum leptin concentration is increased in patients with Beh\u00e7et's syndrome and is correlated with disease activity","volume":"147","author":"Evereklioglu","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.phrs.2018.01.009_bib0635","doi-asserted-by":"crossref","first-page":"6836498","DOI":"10.1155\/2017\/6836498","article-title":"The microbiome in connective tissue diseases and vasculitides: an updated narrative review","volume":"2017","author":"Talotta","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.phrs.2018.01.009_bib0640","first-page":"1026","article-title":"Dyslipidemia in adult dermatomyositis and polymyositisis not associated with anti-lipoprotein lipase","volume":"2","author":"Cotrim","year":"2015","journal-title":"Austin J. Musculoskelet. Disord."},{"issue":"11","key":"10.1016\/j.phrs.2018.01.009_bib0645","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1007\/s10067-016-3347-1","article-title":"The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis","volume":"35","author":"Yin","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.phrs.2018.01.009_bib0650","doi-asserted-by":"crossref","first-page":"709","DOI":"10.6061\/clinics\/2016(12)06","article-title":"Serum adipocytokine profile and metabolic syndrome in young adult female dermatomyositis patients","volume":"71","author":"Silva","year":"2016","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"10.1016\/j.phrs.2018.01.009_bib0655","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jpeds.2011.05.015","article-title":"Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis","volume":"159","author":"Eimer","year":"2011","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.phrs.2018.01.009_bib0660","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1517\/14728222.2015.1025051","article-title":"Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease","volume":"19","author":"Ladeiras-Lopes","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"issue":"20","key":"10.1016\/j.phrs.2018.01.009_bib0665","first-page":"2241","article-title":"The pharmacological mechanisms and therapeutic activities of hydroxychloroquine in rheumatic and related diseases","volume":"24","author":"Curr Hu","year":"2017","journal-title":"Med. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2018.01.009_bib0670","doi-asserted-by":"crossref","first-page":"E1701","DOI":"10.1210\/jc.2014-1976","article-title":"A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome","volume":"99","author":"Straznicky","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0675","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12933-016-0480-8","article-title":"Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study","volume":"15","author":"Rizzo","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2018.01.009_bib0680","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.vph.2015.06.014","article-title":"Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome","volume":"74","author":"Gomaraschi","year":"2015","journal-title":"Vascul. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2018.01.009_bib0685","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11154-014-9298-4","article-title":"Pharmacological treatment and therapeutic perspectives of metabolic syndrome","volume":"15","author":"Lim","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"1","key":"10.1016\/j.phrs.2018.01.009_bib0690","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/gme.0b013e3181e8e1b1","article-title":"Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study","volume":"18","author":"Giordano","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.phrs.2018.01.009_bib0695","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.diabres.2016.08.014","article-title":"Do worms protect against the metabolic syndrome? A systematic review and meta-analysis","volume":"120","author":"Tracey","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"470","key":"10.1016\/j.phrs.2018.01.009_bib0700","first-page":"469","article-title":"Of worms and men\u2013administration of helminth products as an innovative approach to treatment of autoimmune diseases","volume":"31","author":"Sega","year":"2015","journal-title":"Harefuah"},{"issue":"October","key":"10.1016\/j.phrs.2018.01.009_bib0705","article-title":"Effect of the metabolic syndrome on organ damage and mortality in patients with systemic lupus erythematosus: a longitudinal analysis","author":"Mok","year":"2017","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817313348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817313348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:58:58Z","timestamp":1760911138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817313348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":141,"alternative-id":["S1043661817313348"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.01.009","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic syndrome, autoimmunity and rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}